Personalized Stem Cells - FDA Approved Clinical Trials
  • Home
  • Patient
    • FAQ
  • Physician
  • Clinical Trials
    • Knee Osteoarthritis (fully enrolled)
    • COVID-19 Clinical Trials
    • Future Clinical Trials
  • About
    • Personalized Stem Cells
    • Leadership
    • Investors
  • Media
    • News
    • Blog
    • Videos
    • Facebook
  • Contact
  • 833-772-3557
Select Page

Personalized Stem Cells Receives FDA Approval to Treat COVID-19 Patients

by Ashley | Jul 22, 2020 | COVID-19, Press Release

Personalized Stem Cells, Inc. (PSC) has received FDA approval for an Investigational New Drug (IND) application for the treatment of COVID-19 patients with stem cells. The first trial is named “CoronaStem 1” and will provide treatment for 20 hospitalized COVID-19...

Personalized Stem Cells Secures $2.5 Million in Series A Financing Round

by Ashley | Jul 15, 2020 | Press Release

San Diego based regenerative medicine company, Personalized Stem Cells, Inc. (PSC), has secured $2.5 million in a Series A round of financing led by seed investors and key opinion leaders in the field. The funds will enable PSC to complete the current FDA approved...

Interview with CBS Affiliate Regarding Stem Cells for COVID-19

by Ashley | May 1, 2020 | Blog, COVID-19

On April 27, 2020 PSC CEO, Dr. Bob Harman and PSC Medical Director, Dr. Christopher Rogers, were interviewed by San Diego CBS affiliate, KFMB TV.  The interview provides an excellent overview of how Personalized Stem Cells is working with the FDA and the White House...
Copyright © 2022. Personalized Stem Cells. All rights reserved. Privacy Policy
/* First CSS File */ var giftofspeed = document.createElement('link'); giftofspeed.rel = 'stylesheet'; giftofspeed.href = 'https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css'; giftofspeed.type = 'text/css'; var godefer = document.getElementsByTagName('link')[0]; godefer.parentNode.insertBefore(giftofspeed, godefer);